Pneumococcal conjugate vaccine (PCV20)

🧮 Dose calculator

Immunisation (vaccination) · Regimen source: FDA Prevnar 20 · 2.3

• • First dose from 6 weeks. Catch-up (no prior PCV): 7–11 months 3 doses; 12–23 months 2 doses 2 months apart; 24 months–17 y one dose. FDA Prevnar 20 · 2.3FDA Prevnar 20 · 2.4, Table 1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Prevnar 20 · 8.1

  “Risk Summary All pregnancies have a risk of birth defect, loss, or other adverse outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Prevnar 20 · 8.2

  “Data are not available to assess the effects of Prevnar 20 on the breastfed infant or on milk production/excretion.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Prevnar 20 · 8.4

  “The effectiveness of Prevnar 20 for the prevention of otitis media caused by serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F has been established in individuals 6 weeks through 5 years of age [see Clinical Studies (14.1) ] .”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Prevnar 20 · 8.5

  “Of the total number of Prevnar 20 recipients 18 years of age and older evaluated for safety in the 3 main clinical trials (N=4263), 26.7% (n=1138) were 65 years of age and older and 1.7% (n=72) were 80 years of age and older [see Clinical Studies (14.2) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.